These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12055848)

  • 41. Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model.
    Katebi A; Gholami E; Taheri T; Zahedifard F; Habibzadeh S; Taslimi Y; Shokri F; Papadopoulou B; Kamhawi S; Valenzuela JG; Rafati S
    Mol Immunol; 2015 Oct; 67(2 Pt B):501-11. PubMed ID: 26298575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Leishmaniasis: recognition and management with a focus on the immunocompromised patient.
    Choi CM; Lerner EA
    Am J Clin Dermatol; 2002; 3(2):91-105. PubMed ID: 11893221
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coadministration of the Three Antigenic Leishmania infantum Poly (A) Binding Proteins as a DNA Vaccine Induces Protection against Leishmania major Infection in BALB/c Mice.
    Soto M; Corvo L; Garde E; Ramírez L; Iniesta V; Bonay P; Gómez-Nieto C; González VM; Martín ME; Alonso C; Coelho EA; Barral A; Barral-Netto M; Iborra S
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003751. PubMed ID: 25955652
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis.
    Silveira FT; Lainson R; Gomes CM; Laurenti MD; Corbett CE
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1075-80. PubMed ID: 18602127
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy.
    Darcis G; Van der Auwera G; Giot JB; Hayette MP; Tassin F; Arrese Estrada J; Cnops L; Moutschen M; de Leval L; Leonard P
    BMC Infect Dis; 2017 Jul; 17(1):478. PubMed ID: 28687071
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent Advances in Vaccines Against Leishmania Based on Patent Applications.
    Thomaz-Soccol V; Ferreira da Costa ES; Karp SG; Junior Letti LA; Soccol FT; Soccol CR
    Recent Pat Biotechnol; 2018; 12(1):21-32. PubMed ID: 28494723
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of chemokines in regulation of immunity against leishmaniasis.
    Oghumu S; Lezama-Dávila CM; Isaac-Márquez AP; Satoskar AR
    Exp Parasitol; 2010 Nov; 126(3):389-96. PubMed ID: 20206625
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Parasitological and immunological follow-up of American tegumentary leishmaniasis patients.
    Coutinho SG; Pirmez C; Da-Cruz AM
    Trans R Soc Trop Med Hyg; 2002 Apr; 96 Suppl 1():S173-8. PubMed ID: 12055834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of vaccinal effectiveness of preparations containing membrane antigens of Leishmania (L.) amazonensis in experimental cutaneous leishmaniasis model.
    Ribeiro JG; Ferreira AS; Macedo SRA; Rossi NRDLP; da Silva MCP; Guerra RNM; de Barros NB; Nicolete R
    Int Immunopharmacol; 2017 Jun; 47():227-230. PubMed ID: 28433944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification and phylogenetic relationship of Iranian strains of various Leishmania species isolated from cutaneous and visceral cases of leishmaniasis based on N-acetylglucosamine-1-phosphate transferase gene.
    Hajjaran H; Mohebali M; Teimouri A; Oshaghi MA; Mirjalali H; Kazemi-Rad E; Shiee MR; Naddaf SR
    Infect Genet Evol; 2014 Aug; 26():203-12. PubMed ID: 24911282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accurate and rapid species typing from cutaneous and mucocutaneous leishmaniasis lesions of the New World.
    Fraga J; Veland N; Montalvo AM; Praet N; Boggild AK; Valencia BM; Arévalo J; Llanos-Cuentas A; Dujardin JC; Van der Auwera G
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):142-50. PubMed ID: 22819605
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exploring the paradox of defense between host and Leishmania parasite.
    Kumari D; Singh K
    Int Immunopharmacol; 2022 Jan; 102():108400. PubMed ID: 34890999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The clinical and immunological spectrum of American cutaneous leishmaniasis.
    Convit J; Ulrich M; Fernández CT; Tapia FJ; Cáceres-Dittmar G; Castés M; Rondón AJ
    Trans R Soc Trop Med Hyg; 1993; 87(4):444-8. PubMed ID: 8249076
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of acquired immunity in leishmaniasis.
    Howard JG; Liew FY
    Philos Trans R Soc Lond B Biol Sci; 1984 Nov; 307(1131):87-98. PubMed ID: 6151691
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cross-immunity experiments between different species or strains of Leishmania in rhesus macaques (Macaca mulatta).
    Porrozzi R; Teva A; Amaral VF; Santos da Costa MV; Grimaldi G
    Am J Trop Med Hyg; 2004 Sep; 71(3):297-305. PubMed ID: 15381810
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Leishmania donovani: impairment of the cellular immune response against recombinant ornithine decarboxylase protein as a possible evasion strategy of Leishmania in visceral leishmaniasis.
    Yadav A; Amit A; Chaudhary R; Chandel AS; Mahantesh V; Suman SS; Singh SK; Dikhit MR; Ali V; Rabidas V; Pandey K; Kumar A; Das P; Bimal S
    Int J Parasitol; 2015 Jan; 45(1):33-42. PubMed ID: 25449949
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cutaneous and mucocutaneous leishmaniasis.
    Goto H; Lauletta Lindoso JA
    Infect Dis Clin North Am; 2012 Jun; 26(2):293-307. PubMed ID: 22632640
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S; Soto M; Carrión J; Alonso C; Requena JM
    Vaccine; 2004 Sep; 22(29-30):3865-76. PubMed ID: 15364433
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dendritic Cells and Leishmania Infection: Adding Layers of Complexity to a Complex Disease.
    Feijó D; Tibúrcio R; Ampuero M; Brodskyn C; Tavares N
    J Immunol Res; 2016; 2016():3967436. PubMed ID: 26904694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interactions between Neutrophils and Leishmania braziliensis Amastigotes Facilitate Cell Activation and Parasite Clearance.
    Carlsen ED; Jie Z; Liang Y; Henard CA; Hay C; Sun J; de Matos Guedes H; Soong L
    J Innate Immun; 2015; 7(4):354-63. PubMed ID: 25766649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.